The Tixagevimab/cilgavimab cardTixagevimab/cilgavimab

Tixagevimab/cilgavimab

Common

Rarity: Common

The most frequent rarity: most Wikipedia articles become Commons.

Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.

At a glance

Class
Invention
Domain
Science and technology
Knowledge cost
4
In collections
Nobody has pulled it yet.

What Wikipedia says

Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19.

Excerpt from the Wikipedia article “Tixagevimab/cilgavimab”, under the CC BY-SA 4.0 license. Read the article on Wikipedia

Image: Fvasconcellos (talk · contribs), Public domain, via Wikimedia Commons.

Open free boosters and add Tixagevimab/cilgavimab to your collection.

Play for free

Related cards